In more details, the high amount of pancreatic tumor antigens released by CD8+ effector T cells during primary cps therapy can elicit the secretion of tumor‐specific IgG, along with long lasting CD4+ T cell memory. The gene discussed is CD8A; the disease is neoplasm.